AUSTIN, Texas, Aug. 18, 2026 /PRNewswire/ -- Westlake Securities ("Westlake"), a leading middle-market investment bank, is pleased to announce that it served as exclusive financial advisor to SolvChem, Inc. ("SolvChem" or the "Company") in securing an expanded senior credit facility from Amegy Bank, a division of Zions Bancorporation, N.A., to support the Company's continued growth. The transaction marks Westlake's second engagement with SolvChem.
Headquartered in Pearland, Texas, SolvChem is a branded and private-label chemical consumer products manufacturer and chemical distributor, specializing in custom chemical blending and packaging services.
The expanded structure includes advancing term loans that fund the construction and equipping of new production capacity as the project progresses, alongside expanded revolving capacity to support the Company's continued organic growth.
"Expanding this facility was the natural next step in our growth plan. This commitment gives us the capital to keep investing in our capacity and our customers," said Jean-Pierre Baizán, CEO of SolvChem. "Westlake's understanding of our business and their expertise in project finance made this another smooth process from start to finish."
"Closing a second transaction with SolvChem, this time a multi-facility credit structure built around a significant capital project, says everything about the strength of our relationship with the Company and our commitment to serving our clients," said Jon D'Andrea, Managing Director at Westlake Securities. "Jean-Pierre and his team have built a remarkable business, and we look forward to supporting their continued growth."
For more information regarding this transaction or Westlake Securities' advisory services, please contact info@westlakesecurities.com.
About SolvChem
SolvChem, Inc. is a leading diversified chemicals company headquartered in Pearland, Texas. As a family business for over 55 years, SolvChem specializes in custom chemical blending, packaging, and handling services for the top companies and brands in the world. To learn more, visit solvchem.com.
About Amegy Bank
Amegy Bank, a division of Zions Bancorporation, N.A. (NASDAQ: ZION), is a leading Texas bank with $14 billion in assets and about 1,000 employees. Amegy is recognized by Coalition Greenwich as a 2026 Best Bank Award winner, receiving 15 Best Bank Awards for serving middle market and small business clients, placing second in the nation for total awards issued in the middle market banking segment. With more than 75 locations across Houston, Dallas-Fort Worth and Central Texas, Amegy is dedicated to serving Texas communities, families and businesses. To learn more about Amegy Bank, visit amegybank.com. For media inquiries, contact Emmy Bost at emmy.bost@amegybank.com.
About Westlake Securities
Westlake Securities is an award-winning middle-market investment bank founded in 2003 and based in Austin, Texas. The firm has closed over $6.7B in transactions across mergers and acquisitions, private capital placements, and growth advisory for companies throughout the United States. To learn more, visit westlakesecurities.com. Securities and investment banking services are offered through FNEX Capital, LLC, member FINRA/SIPC. Westlake Securities is not affiliated with FNEX Capital.
View original content:https://www.prnewswire.com/news-releases/westlake-securities-secures-expanded-senior-credit-facility-for-solvchem-with-amegy-bank-302853770.html
SOURCE WESTLAKE SECURITIES, LLC
FAQ
What did Amegy Bank (NASDAQ: ZION) provide to SolvChem in August 2026?
Amegy Bank provided an expanded senior credit facility to SolvChem in August 2026. According to Westlake Securities, the structure includes advancing term loans for new production capacity and expanded revolving credit to support SolvChem’s ongoing organic growth initiatives and long-term capital project.
How will SolvChem use the expanded senior credit facility arranged by Westlake Securities?
SolvChem plans to use the expanded facility to fund construction and equipping of new production capacity. According to Westlake Securities, the facility also includes enlarged revolving capacity designed to support SolvChem’s continued organic growth and ongoing investments in operations and customer service.
What role did Westlake Securities play in the SolvChem and Amegy Bank credit facility?
Westlake Securities served as exclusive financial advisor to SolvChem for the expanded senior credit facility. According to Westlake Securities, this was its second engagement with SolvChem and involved structuring a multi-facility credit arrangement around a significant capital project and future production capacity expansion.
Why is the Amegy Bank and SolvChem credit facility relevant for Zions Bancorporation (NASDAQ: ZION) investors?
The facility illustrates Amegy Bank’s ongoing lending to middle-market clients within Texas. According to Amegy Bank, it operates with $14 billion in assets and over 75 Texas locations, and the SolvChem transaction reflects its focus on serving regional business customers, including manufacturers and distributors.
What type of company is SolvChem in the Amegy Bank senior credit facility announcement?
SolvChem is a diversified chemicals company specializing in branded and private-label consumer products. According to SolvChem, it focuses on custom chemical blending, packaging, and handling services, has operated as a family business for over 55 years, and serves major global companies and brands.
What is Amegy Bank’s scale and presence as mentioned alongside the SolvChem credit facility?
Amegy Bank is described as a leading Texas bank with about $14 billion in assets and roughly 1,000 employees. According to Amegy Bank, it operates more than 75 locations across Houston, Dallas-Fort Worth, and Central Texas, focusing on middle market and small business clients.
How experienced is Westlake Securities in advising on transactions like the SolvChem facility?
Westlake Securities reports that it has closed over $6.7 billion in transactions since its founding in 2003. According to Westlake Securities, its experience spans mergers and acquisitions, private capital placements, and growth advisory mandates across the United States, including repeat engagements like SolvChem.
